Due to the modulation of tiny frequency offset on the array elements, a frequency diverse array (FDA) jammer can generate multiple range-dimension point false targets, and many deception jamming methods against SAR using an FDA jammer have been studied. However, the potential of the FDA jammer to generate barrage jamming has rarely been reported. In this paper, a barrage jamming method against SAR using an FDA jammer is proposed. To achieve two-dimensional (2-D) barrage effect, the stepped frequency offset of FDA is introduced to generate range-dimensional barrage patches, and the micro-motion modulation is employed to increase the extent of barrage patches along the azimuth direction. Mathematical derivations and simulation results demonstrate the validity of the proposed method in generating flexible and controllable barrage jamming.
Frequency selective surface is a key component in applications such as communication antenna and remote sensing radiometer. One of the core parameters is selectivity, which is usually realized using a multi-layer structure or through a complicated 3D structure. These methods, however, would impose much challenge on alignment or fabrication. This paper proposes a single-substrate and combined-united array to realize a high selectivity frequency selective surface. The unit cell is a combined pattern of cross dipole and square loop to generate double transmission zeroes out of the passband. Both sides of the substrate are printed with the same pattern to enhance the selectivity. Such a structure enables easy fabrication and assembly by avoiding using multi-substrates. A prototype in the Ku-band demonstrates that both sides of the passband show high selectivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.